TRxADE Health Inc reports results for the quarter ended in December - Earnings Summary

Scienture Holdings

28/03/2023 24:25

* TRxADE Health Inc  MEDS.OQ  reported a quarterly adjusted
loss
of 1 cent​​ per share for the quarter ended in December. The
mean expectation of three analysts for the quarter was for a
loss of 6 cents per share.
    * Revenue rose 5.9% to $2.53 million from a year ago;
analysts
expected $2.51 million. 
    * TRxADE Health Inc's reported EPS for the quarter was a
loss
of 10 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * TRxADE Health Inc shares had risen by 6.8% this quarter.
    * The company reported a quarterly loss of $926 thousand.
    * Wall Street's median 12-month price target for TRxADE
Health Inc
is $2.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 27 at 11:24 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.06          -0.01          Beat
 Sep. 30 2022      -0.12          -0.06          Beat
 Jun. 30 2022      -0.10          -0.13          Missed
 Mar. 31 2022      -0.11          -0.12          Missed